7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
pmid:27930925 | ||||
pmid:27927880 | ||||
pmid:25138264 | ||||
pmid:25125146 | ||||
pmid:27156396 | ||||
pmid:27154288 | ||||
pmid:24929820 | ||||
pmid:24923356 | ||||
pmid:26869171 | ||||
pmid:26862884 | ||||
pmid:24615483 | ||||
pmid:24566391 | ||||
pmid:26556103 | ||||
pmid:26555635 | ||||
pmid:24152296 | ||||
pmid:24138068 | ||||
pmid:26307009 | ||||
pmid:26294373 | ||||
pmid:26062841 | ||||
pmid:26057821 | ||||
pmid:29262817 | ||||
pmid:28957555 | ||||
pmid:25837159 | ||||
pmid:25825337 | ||||
pmid:28244588 | ||||
pmid:25607338 | ||||
pmid:25589510 | ||||
pmid:26438320 | ||||
pmid:27608363 | ||||
pmid:29253005 | ||||
pmid:29121799 | ||||
pmid:25383958 | ||||
pmid:25373482 | ||||
pmid:27582133 | ||||
Wang Y et al. | Puerarin concurrently stimulates osteoprotegerin and inhibits receptor activator of NF-κB ligand (RANKL) and interleukin-6 production in human osteoblastic MG-63 cells. | Phytomedicine | pmid:24854571 | |
pmid:12354528 | ||||
pmid: | ||||
Yamamoto N et al. | Resveratrol reduces prostaglandin E1-stimulated osteoprotegerin synthesis in osteoblasts: suppression of stress-activated protein kinase/c-Jun N-terminal kinase. | Prostaglandins Other Lipid Mediat. | pmid:25677506 | |
Hofbauer LC and Heufelder AE | Osteoprotegerin: a novel local player in bone metabolism. | 1997 | Eur. J. Endocrinol. | pmid:9368500 |
Simonet WS et al. | Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. | 1997 | Cell | pmid:9108485 |
Morinaga T et al. | Cloning and characterization of the gene encoding human osteoprotegerin/osteoclastogenesis-inhibitory factor. | 1998 | Eur. J. Biochem. | pmid:9688283 |
Emery JG et al. | Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. | 1998 | J. Biol. Chem. | pmid:9603945 |
Tsukii K et al. | Osteoclast differentiation factor mediates an essential signal for bone resorption induced by 1 alpha,25-dihydroxyvitamin D3, prostaglandin E2, or parathyroid hormone in the microenvironment of bone. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9610359 |
Mizuno A et al. | Structure of the mouse osteoclastogenesis inhibitory factor (OCIF) gene and its expression in embryogenesis. | 1998 | Gene | pmid:9714833 |
Mizuno A et al. | Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9647741 |
Tsuda E and Higashio K | [Osteoclastogenesis inhibitory factor (OCIF)/OPG]. | 1998 | Nippon Rinsho | pmid:9648461 |
Yamamoto M et al. | Hypocalcemic effect of osteoclastogenesis inhibitory factor/osteoprotegerin in the thyroparathyroidectomized rat. | 1998 | Endocrinology | pmid:9724059 |
Hofbauer LC and Heufelder AE | Osteoprotegerin and its cognate ligand: a new paradigm of osteoclastogenesis. | 1998 | Eur. J. Endocrinol. | pmid:9724069 |
Yun TJ et al. | OPG/FDCR-1, a TNF receptor family member, is expressed in lymphoid cells and is up-regulated by ligating CD40. | 1998 | J. Immunol. | pmid:9834095 |
Murakami T et al. | Transforming growth factor-beta1 increases mRNA levels of osteoclastogenesis inhibitory factor in osteoblastic/stromal cells and inhibits the survival of murine osteoclast-like cells. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9837778 |